• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/16/21 3:06:07 PM ET
    $JWS
    Business Services
    Finance
    Get the next $JWS alert in real time by email
    SC 13G/A 1 d8798224_13g-a.htm

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

     

     

    Jaws Acquisition Corp.
    (Name of Issuer)

     

     

     

    Class A Ordinary Shares, par value $0.0001 per share
    (Title of Class of Securities)

     

     

     

    G50744104
    (CUSIP Number)

     

     

     

    December 31, 2020
    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    [_] Rule 13d-1(b)

     

    [X] Rule 13d-1(c)

     

    [_] Rule 13d-1(d)

     

    __________

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

    CUSIP No. G50744104    

     

    1. NAME OF REPORTING PERSONS  
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
         
      Suvretta Capital Management, LLC  
         
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
        (a)  [_]
        (b)  [x]
         
    3. SEC USE ONLY  
         
         
         
    4. CITIZENSHIP OR PLACE OF ORGANIZATION  
         
      Delaware  
         
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
         
    5. SOLE VOTING POWER  
         
      0  
         
    6. SHARED VOTING POWER  
         
      4,000,000  
         
    7. SOLE DISPOSITIVE POWER  
         
      0  
         
    8. SHARED DISPOSITIVE POWER  
         
      4,000,000  
         
    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
         
      4,000,000  
         
    10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)      [_]
         
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  
         
      5.8%  
         
    12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)  
         
      IA, OO  

     

     

    CUSIP No. G50744104    

     

    1. NAME OF REPORTING PERSONS  
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
         
      Suvretta Master Fund, Ltd.  
         
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
        (a)  [_]
        (b)  [x]
         
    3. SEC USE ONLY  
         
         
         
    4. CITIZENSHIP OR PLACE OF ORGANIZATION  
         
      Cayman Islands  
         
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
         
    5. SOLE VOTING POWER  
         
      0  
         
    6. SHARED VOTING POWER  
         
      3,953,310  
         
    7. SOLE DISPOSITIVE POWER  
         
      0  
         
    8. SHARED DISPOSITIVE POWER  
         
      3,953,310  
         
    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
         
      3,953,310  
         
    10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)      [_]
         
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  
         
      5.7%  
         
    12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)  
         
      CO  
           

     

     

    CUSIP No. G50744104    

     

    1. NAME OF REPORTING PERSONS  
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
         
      Aaron Cowen  
         
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
        (a)  [_]
        (b)  [x]
         
    3. SEC USE ONLY  
         
         
         
    4. CITIZENSHIP OR PLACE OF ORGANIZATION  
         
      U.S.A.  
         
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
         
    5. SOLE VOTING POWER  
         
      0  
         
    6. SHARED VOTING POWER  
         
      4,000,000  
         
    7. SOLE DISPOSITIVE POWER  
         
      0  
         
    8. SHARED DISPOSITIVE POWER  
         
      4,000,000  
         
    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
         
      4,000,000  
         
    10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)      [_]
         
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  
         
      5.8%  
         
    12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)  
         
      IN, HC  

     

     

    CUSIP No. G50744104    

     

    Item 1. (a). Name of Issuer:
         
        Jaws Acquisition Corp.
         
      (b). Address of Issuer's Principal Executive Offices:
         
       

    1601 Washington Avenue, Suite 800

    Miami Beach, FL 33139

         
         
    Item 2. (a) – (c) Name, Principal Business Address, and Citizenship of Persons Filing:
         
       

    Suvretta Capital Management, LLC – Delaware

    Suvretta Master Fund, Ltd. – Cayman Islands

        Aaron Cowen – U.S.A.
         
       

    Suvretta Capital Management, LLC:

    540 Madison Avenue, 7th Floor

    New York, New York 10022

       

    United States of America

     

    Suvretta Master Fund, Ltd.:

    c/o Maples Corporate Services Limited

    P.O. Box 309

    Ugland House

    Grand Cayman KY1-1104

    Cayman Islands

     

    Aaron Cowen:

    c/o Suvretta Capital Management, LLC

    540 Madison Avenue, 7th Floor

    New York, New York 10022

         
      (d).   Title of Class of Securities:
         
        Class A Ordinary Shares, par value $0.0001 per share (“Class A Ordinary Shares”)
         
      (e). CUSIP Number:
         
        G50744104

     

     

    Item 3.   If This Statement is filed pursuant to ss.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a

     

      (a) [_] Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78c).
           
      (b) [_] Bank as defined in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c).
           
      (c) [_] Insurance company as defined in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c).
           
      (d) [_] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
           
      (e) [_] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
           
      (f) [_] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
           
      (g) [_] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
           
      (h) [_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);
           
      (i) [_] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
           
      (j)   [_] Group, in accordance with s.240.13d-1(b)(1)(ii)(J).

     

     
    Item 4. Ownership.
     
    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

      (a)   Amount beneficially owned:
         
        Suvretta Capital Management, LLC – 4,000,000
        Suvretta Master Fund, Ltd. – 3,953,310
        Aaron Cowen – 4,000,000
         
      (b)   Percent of class:
         
        Suvretta Capital Management, LLC – 5.8%
        Suvretta Master Fund, Ltd. – 5.7%
        Aaron Cowen – 5.8%
         
      (c)   Number of shares as to which the person has:
         
        (i) Sole power to vote or to direct the vote  
             
          Suvretta Capital Management, LLC – 0
          Suvretta Master Fund, Ltd. – 0
          Aaron Cowen – 0
             
        (ii)   Shared power to vote or to direct the vote  
             
          Suvretta Capital Management, LLC – 4,000,000
          Suvretta Master Fund, Ltd. – 3,953,310
          Aaron Cowen – 4,000,000
             
        (iii) Sole power to dispose or to direct the disposition of  
             
          Suvretta Capital Management, LLC – 0
          Suvretta Master Fund, Ltd. – 0
          Aaron Cowen – 0
             
        (iv)   Shared power to dispose or to direct the disposition of  
             
          Suvretta Capital Management, LLC – 4,000,000
          Suvretta Master Fund, Ltd. – 3,953,310
          Aaron Cowen – 4,000,000

     

     

    Item 5. Ownership of Five Percent or Less of a Class.
     
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [_].
     
      N/A
       
       
    Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than five percent of the class, such person should be identified.  A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
     
      All securities reported in this Schedule 13G are owned by advisory clients of Suvretta Capital Management, LLC.  None of the advisory clients, with the exception of Suvretta Master Fund, Ltd., individually owns more than 5% of the outstanding shares of Class A Ordinary Shares.  
       
       
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary.  If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
     
      See Exhibit B attached hereto.
       
       
    Item 8. Identification and Classification of Members of the Group.
     
    If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group.  If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
     
      N/A
       
       
    Item 9. Notice of Dissolution of Group.
     
    Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity.  See Item 5.
     
      N/A
       
       
    Item 10. Certification.
     
      (b) The following certification shall be included if the statement is filed pursuant to §240.13d-1(c):
         
        By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

      February 16, 2021
      (Date)
       
      Suvretta Capital Management, LLC*
       
      By:  /s/ Aaron Cowen
      (Signature)
       
      Authorized Signatory
     

    (Name/Title)

     

    Suvretta Master Fund, Ltd.*

       
      By:  /s/ Aaron Cowen
      (Signature)
       
      Director
      (Name/Title)
     

     

    Aaron Cowen*

     

      /s/ Aaron Cowen
      (Signature)
       
       

    *The Reporting Persons disclaim beneficial ownership over the securities reported herein except to the extent of the Reporting Persons’ pecuniary interest therein.

     

    The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

    Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See s.240.13d-7 for other parties for whom copies are to be sent.

    Attention. Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

     

     

     

    Exhibit A

     

    AGREEMENT

     

    The undersigned agree that this Schedule 13G dated February 16, 2021 relating to the Class A Ordinary Shares, par value $0.0001 per share of Jaws Acquisition Corp. shall be filed on behalf of the undersigned.

      February 16, 2021
      (Date)
       
      Suvretta Capital Management, LLC
       
      By:  /s/ Aaron Cowen
      (Signature)
       
      Authorized Signatory
     

    (Name/Title)

     

    Suvretta Master Fund, Ltd.

       
      By:  /s/ Aaron Cowen
      (Signature)
       
      Director
      (Name/Title)
     

     

    Aaron Cowen

     

      /s/ Aaron Cowen
      (Signature)
       
       

     

     

     

    Exhibit B

     

    Aaron Cowen has beneficial ownership by virtue of his role as a control person of Suvretta Capital Management, LLC.

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Get the next $JWS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $JWS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $JWS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by Morales Angel L

    3 - Cano Health, Inc. (0001800682) (Issuer)

    6/23/21 3:06:35 PM ET
    $JWS
    Business Services
    Finance

    SEC Form 3 filed by TRUJILLO SOLOMON D

    3 - Cano Health, Inc. (0001800682) (Issuer)

    6/15/21 7:12:01 PM ET
    $JWS
    Business Services
    Finance

    SEC Form 3 filed by Gold Lewis

    3 - Cano Health, Inc. (0001800682) (Issuer)

    6/15/21 6:44:37 PM ET
    $JWS
    Business Services
    Finance

    $JWS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cano Health Closes Business Combination with Jaws Acquisition Corp. and Will Begin Trading on the New York Stock Exchange

    MIAMI, June 3, 2021 /PRNewswire/ -- Cano Health, Inc. ("Cano Health," the "Company," "we," "our" or "us"), a leading value-based primary care provider for seniors and underserved communities, today announced it has completed its business combination with Jaws Acquisition Corp. ("Jaws") (NYSE: JWS). The business combination, which was approved by Jaws' stockholders at its special meeting held on June 2, 2021, will enable Cano Health to achieve its vision of becoming America's leader in primary care and accelerate the Company's growth. Beginning June 4, 2021, Cano Health's shares of Class A common stock will trade on the New York Stock Exchange ("NYSE") under the symbol "CANO." "This is an imp

    6/3/21 4:10:00 PM ET
    $JWS
    Business Services
    Finance

    Jaws Acquisition Corp. Announces Extraordinary General Meeting Teleconference Details

    MIAMI, May 24, 2021 /PRNewswire/ -- Jaws Acquisition Corp. ("Jaws") (NYSE:JWS), today announced that, due to the public health and safety concerns related to the coronavirus (COVID-19) pandemic and recommendations and orders from federal and New York authorities, it is strongly encouraging that shareholders attend the extraordinary general meeting of its shareholders, which will be held on June 2, 2021 at 9:00 a.m., New York City Time (the "General Meeting"), by teleconference rather than in person. The purpose of the General Meeting is to vote on certain proposals relating to the previously announced merger between Jaws and Cano Health, LLC ("Cano Health" or the "Company"), the related Busi

    5/24/21 8:00:00 AM ET
    $JWS
    Business Services
    Finance

    Jaws Acquisition Corp. Announces Effectiveness of Registration Statement and Sets Special Meeting Date for Proposed Business Combination with Cano Health

    MIAMI, May 10, 2021 /PRNewswire/ -- Jaws Acquisition Corp. (NYSE:JWS), a special purpose acquisition company ("Jaws"), announced today the effectiveness of its Registration Statement, in connection with its previously announced merger with Cano Health, LLC ("Cano Health"), on Form S-4, with the United States Securities and Exchange Commission (the "SEC"). Jaws also announced a special meeting of its shareholders (the "Special Meeting") to approve the proposed merger agreement with Cano Health for June 2, 2021 at 9:00 a.m., Eastern Time, unless postponed or adjourned to a later date or time. Jaws will distribute the definitive proxy statement and proxy card to its stockholders of record as of

    5/10/21 8:00:00 AM ET
    $JWS
    Business Services
    Finance

    $JWS
    SEC Filings

    View All

    SEC Form 8-K filed by Jaws Acquisition Corp.

    8-K - Cano Health, Inc. (0001800682) (Filer)

    7/6/21 6:42:14 AM ET
    $JWS
    Business Services
    Finance

    SEC Form S-1 filed by Jaws Acquisition Corp.

    S-1 - Cano Health, Inc. (0001800682) (Filer)

    6/25/21 5:28:55 PM ET
    $JWS
    Business Services
    Finance

    Jaws Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Cano Health, Inc. (0001800682) (Filer)

    6/14/21 6:30:29 AM ET
    $JWS
    Business Services
    Finance

    $JWS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Jaws Acquisition Corp.

    SC 13D - Cano Health, Inc. (0001800682) (Subject)

    6/14/21 5:21:02 PM ET
    $JWS
    Business Services
    Finance

    SEC Form SC 13G filed by Jaws Acquisition Corp.

    SC 13G - Jaws Acquisition Corp. (0001800682) (Subject)

    4/5/21 8:30:35 AM ET
    $JWS
    Business Services
    Finance

    SEC Form SC 13G/A filed

    SC 13G/A - Jaws Acquisition Corp. (0001800682) (Subject)

    2/16/21 3:06:07 PM ET
    $JWS
    Business Services
    Finance